Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.
复制标题
DOI:
10.1126/science.abf6950
复制
发表时间:
2021-03-12
期刊:
影响因子:
--
通讯作者:
Duprex WP
中科院分区:
文献类型:
--
作者:
McCarthy KR;Rennick LJ;Nambulli S;Robinson-McCarthy LR;Bain WG;Haidar G;Duprex WP
Influenza viruses evade immunity initiated by previous infection, which explains recurrent influenza pandemics. Unlike the error-prone RNA-dependent RNA polymerase of influenza, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related viruses contain polymerases with proofreading activity. However, proofreading cannot correct deletions, which during a long-term persistent infection could result in the generation of viruses showing alteration of entire stretches of amino acids and the structures they form. McCarthy et al. identified an evolutionary signature defined by prevalent and recurrent deletions in the spike protein of SARS-CoV-2 at four antigenic sites. Deletion variants show human-to-human transmission of viruses with altered antigenicity. Science, this issue p. 1139 SARS-CoV-2 genome deletions that arise independently in persistently infected individuals show recurrent and convergent evolution. Zoonotic pandemics, such as that caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can follow the spillover of animal viruses into highly susceptible human populations. The descendants of these viruses have adapted to the human host and evolved to evade immune pressure. Coronaviruses acquire substitutions more slowly than other RNA viruses. In the spike glycoprotein, we found that recurrent deletions overcome this slow substitution rate. Deletion variants arise in diverse genetic and geographic backgrounds, transmit efficiently, and are present in novel lineages, including those of current global concern. They frequently occupy recurrent deletion regions (RDRs), which map to defined antibody epitopes. Deletions in RDRs confer resistance to neutralizing antibodies. By altering stretches of amino acids, deletions appear to accelerate SARS-CoV-2 antigenic evolution and may, more generally, drive adaptive evolution.
登录
查看更多内容
影响因子:
10.7
作者:
Price MN;Dehal PS;Arkin AP
通讯作者:
Arkin AP
DOI:
10.1099/jgv.0.001481
发表时间:
2020-11
期刊:
The Journal of general virology
影响因子:
--
作者:
Klimstra WB;Tilston-Lunel NL;Nambulli S;Boslett J;McMillen CM;Gilliland T;Dunn MD;Sun C;Wheeler SE;Wells A;Hartman AL;McElroy AK;Reed DS;Rennick LJ;Duprex WP
通讯作者:
Duprex WP
DOI:
10.1093/cid/ciab072
发表时间:
2021-08-02
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Hensley MK;Bain WG;Jacobs J;Nambulli S;Parikh U;Cillo A;Staines B;Heaps A;Sobolewski MD;Rennick LJ;Macatangay BJC;Klamar-Blain C;Kitsios GD;Methé B;Somasundaram A;Bruno TC;Cardello C;Shan F;Workman C;Ray P;Ray A;Lee J;Sethi R;Schwarzmann WE;Ladinsky MS;Bjorkman PJ;Vignali DA;Duprex WP;Agha ME;Mellors JW;McCormick KD;Morris A;Haidar G
通讯作者:
Haidar G
影响因子:
10.7
作者:
Katoh K;Standley DM
通讯作者:
Standley DM
影响因子:
64.5
作者:
Volz E;Hill V;McCrone JT;Price A;Jorgensen D;O'Toole Á;Southgate J;Johnson R;Jackson B;Nascimento FF;Rey SM;Nicholls SM;Colquhoun RM;da Silva Filipe A;Shepherd J;Pascall DJ;Shah R;Jesudason N;Li K;Jarrett R;Pacchiarini N;Bull M;Geidelberg L;Siveroni I;COG-UK Consortium;Goodfellow I;Loman NJ;Pybus OG;Robertson DL;Thomson EC;Rambaut A;Connor TR
通讯作者:
Connor TR